Table 3.
Interaction analysis of association between TG and CVD risk
| Covariate | HR* (95% CI) |
p-value |
|---|---|---|
| Age @ | ||
| 50 years | 1.82 (1.37 - 2.42) | 0.178 |
| 60 years | 1.50 (1.33 - 1.69) | |
| Sex | ||
| Female | 1.76 (1.47 - 2.12) | 0.021 |
| Male | 1.33 (1.14 - 1.56) | |
| BMI @ | ||
| 25 kg/m2 | 1.56 (1.34 - 1.82) | 0.607 |
| 30 kg/m2 | 1.52 (1.34 - 1.72) | |
| Diabetes | ||
| No | 1.45 (1.25 - 1.68) | 0.274 |
| Yes | 1.25 (1.00 - 1.56) | |
| Statins | ||
| No | 1.58 (1.40 - 1.79) | 0.673 |
| Yes | 1.44 (0.95 - 2.18) | |
| LDL-C @ | ||
| 80 mg/dL | 1.57 (1.29 - 1.91) | 0.682 |
| 120 mg/dL | 1.62 (1.42 - 1.85) | |
| 165 mg/dL | 1.68 (1.36 - 2.07) | |
| HDL-C @ | ||
| 40 mg/dL | 1.32 (1.13 - 1.53) | 0.014 |
| 50 mg/dL | 1.55 (1.29 - 1.86) | |
| 60 mg/dL | 1.68 (1.37 - 2.06) | |
BMI, body mass index; CI, confidence interval; CVD, cardiovascular disease; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride
*
Hazard ratio represents the change in hazard due to a doubling of triglyceride levels.